R E G IS T R A T I O N D OS S I E R S A V A I L A B L E RE TAI L MA RKE T (WHOL ESAL ER S AND PH ARM AC IES) MOLECULE REFERENCE PRODUCT
Acyclovir Dexketoprofen
Solution for injection/Concentrate for solution for
Doxazosin
Fluoxetine Gabapentin Glimepiride
Glucosamine Sulphate
Ibuprofen-lysine
Memantine Mirtazapine Pantoprazole Quetiapine Venlafaxine
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
R E G IS T R A T I O N D OS S I E R S A V A I L A B L E HOSPI TA L MA RKE T MOLECULE REFERENCE PRODUCT
Acyclovir
Lyophilised powder for solution for infusion
Amoxicillin + clavulanic acid
Cefepime
Cefonicid
Powder and solvent for solution for injection
Cefotaxime
Powder and solvent for solution for injection
Powder and solvent for solution for injection/infusion
Ceftazidime Powder and solvent for solution for injection
Ceftriaxone Powder and solvent for solution for injection Cis-atracurium
2 mg/mL (5 mL and 10 mL), 5 mg/mL (30 mL)
Cefuroxime (Sodium)
Powder and solvent for solution for injection
Powder for solution for injection/infusion
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
R E G IS T R A T I O N D OS S I E R S A V A I L A B L E HOSPI TA L MA RKE T MOLECULE REFERENCE PRODUCT
Clindamycin
150 mg/ml (300 mg/2 ml, 600 mg/4 ml, 900 mg/6 ml)
Dexketoprofen
Solution for injection/Concentrate for solution for
Fluconazole
Flumazenil
Granisetron
Iron sucrose
Solution for injection/concentrate solution for infusion 20 mg/ml
Ketorolac Trometamol
Levofloxacin Meropenem
Midazolam
1 mg/ml (5 mg/5 ml), 5 mg/ml (15 mg/3 ml and 50 mg/10 ml)
Pamidronate
Lyophilised powder for solution for infusion
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries. April 2010
R E G IS T R A T I O N D OS S I E R S A V A I L A B L E HOSPI TA L MA RKE T MOLECULE REFERENCE PRODUCT Pantoprazole
Lyophilised powder for solution for injection/infusion
Paracetamol
Phenytoin
Piperacillin/Tazobactam Lyophilised powder and solvent for solution for injection
Lyophilised powder for solution for injection
Remifentanil
Lyophilised powder for solution for injection/infusion
Stilamin® (Serono, IT, NL, CH.)Somatostatin
Lyophilised powder and solvent for solution for infusion
Modustatine® (Clin Midy, FR.) Teicoplanina
Lyophilised powder and solvent for solution for injection
Vancomycin
Lyophilised powder for solution for injection
Zidovudine Capsules Zoledronic
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries.
Robert S. Berry, M.D. Because of the charitable nature of the clinic, I had consideredmaking it a non-profit to take advantage of tax breaks and to raiseThe greatest benefit of an insurance-free practice is justmoney for my own salary. After several discussions with myattorney, I was inclined to decide against it. He pointed out thatMore than three years ago, I left emergency medicine to s
Science, Art and Drug Discovery, A Personal Perspective Simon F. Campbell, PhD FRS Formerly Senior Vice President, WW Discovery, Pfizer Central Research The pharmaceutical industry is under intense pressure to increase productivity, and drug discovery is undergoing a paradigm shift whereby the explosion in genome sciences and new technologies is being harnessed to produce innovative th
R E G IS T R A T I O N D OS S I E R S A V A I L A B L E 
R E G IS T R A T I O N D OS S I E R S A V A I L A B L E